Shared filing · public exchange announcement

OthersReg. 34 (1) Annual Report

AMS Polymers FY2025-26: Revenue ₹109.60 cr; PAT ₹7.88 cr? actually ₹0.79 cr; margins pressured; auditor change; no dividend.

Financial highlights

  • Revenue from operations: ₹1,095.97 crore; total income: ₹1,096.33 crore.
  • PAT: ₹7.88 million (₹0.79 crore) for FY2025-26.
  • Basic EPS: ₹2.39; book value per share: ₹18.27.
  • Revenue growth 8.55% and net profit growth 2.60% YoY.
  • Dividend not declared due to insufficient profits.
  • Net worth approx ₹6.03 crore; total borrowings ₹13.13 crore.
  • Debt mix: secured ₹4.33 crore; unsecured ₹8.79 crore.
  • Auditors changed to M/s KVA & Company for 2026-31.

Operations & product mix

  • Single reportable segment: trading and manufacturing of specialty chemicals.
  • Full-year revenue ₹109.60 crore; quarterly net sales about ₹26.7–28.5 crore.
  • Net margin about 0.72%; profitability remains modest.
  • Product diversification across PU resins, adhesives, coatings, primers, binders, sealants.
  • Prices and raw-material volatility continue to pressure margins.

Capital structure & liquidity

  • Total borrowings ₹13.13 crore; secured ₹4.33 crore; unsecured ₹8.79 crore.
  • Current ratio 1.12x; debt-equity 2.40x.
  • Paid-up equity ₹3.3025 crore; shares issued: 3,302,500.
  • Closing cash ₹0.19 million; net cash from operations ₹5.33 million.
  • Net cash used in investing ₹1.92 million; overall net cash flow ₹−2.07 million.

Governance & audit

  • Roshan Agarwal & Associates resigned; M/s KVA & Company appointed as statutory auditors.
  • Auditors’ term proposed from AGM 2026 to 2031; subject to Members’ approval.
  • Secretarial auditor: M/s Kundan Agrawal & Associates; no qualifications.
  • Board size 5; 2 executive, 2 independent women, 1 non-executive.
  • Nine board meetings; one independent directors’ meeting on 20-03-2026.

Related party transactions

  • Annu Industries—purchases ₹90.71 crore; sales ₹12.25 crore; board approvals in 2025.
  • Shreshtha Securities—unsecured loan; outstanding ₹15.55 lakh; infusion ₹63.05 lakh.
  • MD/Director loans up to ₹1.5 crore each (Anand Kumar, Arpit Goel, Amber Goel).
  • Aggregate limits for loans/investments up to ₹15–₹20 crore under Sections 185/186.

Outlook & risks

  • Revenue growth expected; margins require improvement due to cost pressures.
  • Opportunities in polyurethane, construction chemicals, expanded exports.
  • Risks include raw-material volatility, competition, and regulatory shifts.
  • Strategy emphasizes higher-margin products, cost control, and working-capital discipline.
Filed 3 Sept 2026, 11:33 pm IST
Source

StocksBriefer summaries are for informational use only. Verify material decisions against the original exchange filing.